About the Epidermolysis Bullosa Session
Epidermolysis Bullosa (EB) is a group of rare genetic skin disorders characterized by extreme fragility of the skin and mucous membranes. In individuals with EB, even minor trauma or friction can cause severe blisters and wounds, leading to significant pain and risk of infection. There are several types of EB, ranging from mild to severe, with varying impacts on quality of life.
In dermatology, effective management focuses on wound care, pain control, and preventing complications. Dermatologists play a crucial role in developing individualized treatment plans, which may include advanced dressings and topical therapies. Cosmetology can also offer supportive strategies, such as using gentle skincare products and techniques that minimize skin trauma. Collaborative care between dermatologists and cosmetologists is essential for enhancing the well-being and self-esteem of individuals with EB.
Featured Speakers — Epidermolysis Bullosa 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Epidermolysis Bullosa Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Epidermolysis Bullosa Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Epidermolysis Bullosa work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Epidermolysis Bullosa research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same programme, same certificate.
Join IDC 2027 for the Epidermolysis Bullosa track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Epidermolysis Bullosa Conference 2027 — FAQs
What is the Epidermolysis Bullosa track at IDC 2027?
The Epidermolysis Bullosa track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Epidermolysis Bullosa. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Epidermolysis Bullosa sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Epidermolysis Bullosa are all welcome — whether presenting or attending.
Can I present my research in the Epidermolysis Bullosa track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Epidermolysis Bullosa sessions?
Yes. IDC 2027 is a hybrid conference — attend the Epidermolysis Bullosa track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.